Cellectar Biosciences, Inc.

CLRBCIK 0001279704 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed Apr 30, 2026. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone -0.0016

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

May 18, 2026no items parsed May 14, 2026no items parsed May 8, 2026no items parsed Mar 4, 2026no items parsed Nov 13, 2025no items parsed

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Cellectar Biosciences, Inc.

Name	Roles	Filings
Longcor Jarrod	Officer	8
Caruso James V	OfficerDirector	7
Kolean Chad J	Officer	6
Neis John	Director	4
Chanan-Khan Asher	Director	3

Showing 1-5 of 11

Per pagePage 1 of 3Next

All filings

43 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Feb 18, 2025	Kolean Chad J Chief Financial Officer	Holdings only	-	-	-

Filed		Top transaction	Shares	Price	Value